枢纽基因PRPF19和PPIB:COPD中的分子途径和潜在生物标志物
Jiale Zhao1,2, Xiahui Ge3, Hailong Li4
1School of Clinical Medicine, Ningxia Medical University, Yinchuan, Ningxia, People's Republic of China.
基因分析确定PRPF19和PPIB是慢性阻塞性肺病 (COPD) 的潜在生物标志物. 这些基因在COPD患者中表现异常,这表明它们在疾病的发展和诊断中起着作用.
科学领域:
- 基因组学就是基因组学.
- 呼吸系统医学 呼吸系统医学
- 分子生物学分子生物学
背景情况:
- 慢性阻塞性肺病 (COPD) 是一种复杂的呼吸系统疾病,受遗传和环境因素的影响.
- 了解COPD的遗传基础对于开发有效的诊断和治疗至关重要.
- 确定因果遗传联系对于推进COPD研究至关重要.
研究的目的:
- 确定导致慢性阻塞性肺病 (COPD) 的遗传因素.
- 探索特定基因与COPD之间的因果关系.
- 为了验证潜在的COPD诊断生物标志物.
主要方法:
- 全基因组DNA甲基化分析和基因表达概况 (GEO数据集GSE38974).
- 权重基因共同表达网络分析 (WGCNA) 和蛋白质-蛋白质相互作用 (PPI) 网络分析以确定枢纽基因.
- 门德尔随机化 (MR) 分析用于因果推断和RT-qPCR,免疫组织化学和西部斑点用于验证.
主要成果:
- 在COPD中确定了10,593个差异甲基化基因 (DMGs) 和646个差异表达基因 (DEGs).
- 确定了五个枢纽基因 (PPIB,HSPA2,PRPF19,FKBP10,DOHH),其中PRPF19和PPIB显示出显著的关联.
- 验证证实了COPD患者外周血液和肺组织中PRPF19和PPIB表达的上调.
结论:
- PRPF19和PPIB显示出作为COPD诊断生物标志物的潜力.
- 这些基因可能在COPD的发病过程中发挥重要作用.
- 需要进一步的研究来充分了解PRPF19和PPIB在COPD中的作用.
更多相关视频
07:01Navigating the Mass Spectrometry-Based Proteomic Data Using Free Computational Tools
Published on: August 19, 2025
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
相关概念视频
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
